Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Fuelling Innovation

17 July 2013

[Re: London is now the UK’s uncontested entrepreneurial powerhouse, Monday, City AM]
This article misses one huge asset for building an enterprise culture in the UK – our universities. In London, world leaders provide a hub for innovating and spinning-out business in everything from biotechnology to apps.

Last year, they supported 1,400 active spin-outs and startups in the capital alone. Despite these successes, London’s universities remain underutilised for economic benefit. It’s time for universities and businesses in London to recognise their strengths and work more closely together to fuel innovation and prosperity.
Professor Stephen Caddick, UCL

From City AM Letters to the Editor 17th July 2013